Loading
2cureX AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 28 Apr 2026.
2cureX AB: what insiders have been doing
2cureX AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. 1 insider has disclosed 1 filing since 18 October 2025.
Only purchases show up on the open market, 1 purchase in all worth €349k, filed by 1 insider. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 board member among the declarants. Biggest ticket of the year: €349k, bought by Ole Thastrup and made public on 28 April 2026 (9.8% of market cap).
The most recent open-market purchase was published on 28 April 2026, 173 days ago.
With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 886 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 1 purchase and 1 sale.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€349,377
1 ops. · all time
Sell Volume
€20,637
1 ops. · all time
Who traded when
BuySaleOle Thastrup1 buy
Since the insiders bought
- -4.6%Entry SEK 1.95 · Close at T+90 SEK 1.86
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2024FY ended December 2024 · cache
SEK 0.60
Analyst consensus
Income statement
EBITDA-SEK 4.5M
Net income-SEK 4.6M0.0% margin
Valuation
P/Book3.8x
Beta3.01
Balance sheet & cash
Market capSEK 15.1M
Free Cash Flow-SEK 4.6M
Profitability & ownership
ROE-174.8%
ROA-98.0%
% insiders44.2%
% institutions9.3%
Last declaration on 28 April 2026
Declarations3 total
3,460,134 shares@ SEK 1.0899.80% mcap100.0% of flowAktieISIN SE0010468124FI:A003X897-1
Canonical exit: 21 Jul 2026 (T+90)
10,600 shares@ SEK 19.75100.0% of flowAktieISIN SE0010468124FI:A001P631-1
31,800 shares0WarrantFI:A001P350-1
3 of 3 declarations
About 2cureX AB
2cureX AB is a company focused on developing diagnostic solutions for cancer treatment. It operates in the healthcare and pharmaceutical sector, listed on the XSTO market.
